News from IrsiCaixa

All the news in a click

The evolution of hepatitis C virus therapies

Of 72 antivirals tested in the laboratory, plitidepsin proves to be the most effective in preventing SARS-CoV-2 replication

Therapeutic HIV vaccine achieves an immune response that improves viral control when antiretroviral treatment is interrupted

Both antibodies generated by vaccination and by natural infection block the SARS-CoV-2 variant described in England

Condolences for the loss of Charles Boucher

Recommendations on vaccination of people with evidence of previous SARS-CoV-2 infection

Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence

Announcement on the new SARS-CoV-2 strain, variant VUI-202012/01

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: